| 1 | Abdominal Neoplasms | 30% |
| 2 | Head and Neck Neoplasms | 30% |
| 3 | Soft Tissue Neoplasms | 30% |
| 4 | Thoracic Neoplasms | 30% |
| 5 | Digestive System Neoplasms | 23.1% |
| 6 | Endocrine Gland Neoplasms | 23.1% |
| 7 | Nervous System Neoplasms | 23.1% |
| 8 | Bone neoplasms | 22.2% |
| 9 | Retinal Degeneration | 22.2% |
| 10 | Skin Neoplasms | 22.2% |
| 11 | Hematologic Neoplasms | 22.2% |
| 12 | Retroperitoneal Neoplasms | 22% |
| 13 | Splenic Neoplasms | 21.8% |
| 14 | Parathyroid Neoplasms | 21.4% |
| 15 | Peritoneal Neoplasms | 21.4% |
| 16 | Thyroid Neoplasm | 21.4% |
| 17 | Thyroid carcinoma | 21.4% |
| 18 | Asthenopia | 21.1% |
| 19 | Conjunctival Diseases | 21.1% |
| 20 | Corneal Diseases | 21.1% |
| 21 | Eyelid Diseases | 21.1% |
| 22 | Lacrimal Apparatus Diseases | 21.1% |
| 23 | Lens Diseases | 21.1% |
| 24 | Ocular Hypertension | 21.1% |
| 25 | Ocular Hypotension | 21.1% |
| 26 | Retinal Diseases | 21.1% |
| 27 | Scleral Diseases | 21.1% |
| 28 | Vitreous Detachment | 21.1% |
| 29 | Posterior Vitreous Detachment | 21.1% |
| 30 | Acanthoma | 20.4% |
| 31 | Xerophthalmia | 20% |
| 32 | Low Tension Glaucoma | 20% |
| 33 | Iridocorneal endothelial syndrome | 20% |
| 34 | Tracheal Neoplasms | 19.5% |
| 35 | Keratoconjunctivitis Sicca | 19.4% |
| 36 | Eyelid Neoplasms | 19.4% |
| 37 | Paraneoplastic Encephalomyelitis | 18.8% |
| 38 | Chorioretinitis | 18.8% |
| 39 | Mammary Neoplasms, Experimental | 18.4% |
| 40 | Pancreatic Neoplasm | 18.4% |
| 41 | Retinal Dysplasia | 18.4% |
| 42 | Pars Planitis | 18% |
| 43 | Keratoconjunctivitis | 17.9% |
| 44 | Blepharophimosis | 17.4% |
| 45 | Multiple Endocrine Neoplasia | 17.3% |
| 46 | Retinal Hemorrhage | 17.3% |
| 47 | Thyroid Nodule | 17.2% |
| 48 | Aniridia | 17.2% |
| 49 | Mouth Neoplasms | 16.4% |
| 50 | Central Nervous System Neoplasms | 16.4% |
| 51 | Vascular Neoplasms | 16.4% |
| 52 | Thymus Neoplasms | 16.4% |
| 53 | Choroiditis | 16.3% |
| 54 | Iridocyclitis | 16.3% |
| 55 | Iritis | 16.3% |
| 56 | Esophageal Neoplasms | 16.3% |
| 57 | Genital Neoplasms, Female | 16.1% |
| 58 | Breast Neoplasms, Male | 15.9% |
| 59 | Triple Negative Breast Neoplasms | 15.9% |
| 60 | Hamartoma | 15.8% |
| 61 | Neoplasms, Hormone-Dependent | 15.8% |
| 62 | Neoplasms, Multiple Primary | 15.8% |
| 63 | Paraneoplastic Syndromes | 15.8% |
| 64 | Precancerous Conditions | 15.8% |
| 65 | Neoplasms, Second Primary | 15.8% |
| 66 | Corneal Ulcer | 15.7% |
| 67 | Carcinoma, Lobular | 15.7% |
| 68 | Choroid Hemorrhage | 15.6% |
| 69 | Eye Abnormalities | 15.4% |
| 70 | Eye Infection | 15.4% |
| 71 | Eye Manifestations | 15.4% |
| 72 | Optic Neuropathy | 15.4% |
| 73 | Angioid Streaks | 15% |
| 74 | Anisometropia | 15% |
| 75 | Aphakia | 15% |
| 76 | Astigmatism | 15% |
| 77 | Blepharitis | 15% |
| 78 | Blepharoptosis | 15% |
| 79 | Blepharospasm | 15% |
| 80 | Choroid Diseases | 15% |
| 81 | Conjunctivitis | 15% |
| 82 | Corneal edema | 15% |
| 83 | Corneal Opacity | 15% |
| 84 | Dacryocystitis | 15% |
| 85 | Dry Eye Syndromes | 15% |
| 86 | Ectropion | 15% |
| 87 | Enophthalmos | 15% |
| 88 | Entropion | 15% |
| 89 | Episcleritis | 15% |
| 90 | Exophthalmos | 15% |
| 91 | Glaucoma | 15% |
| 92 | Iris Diseases | 15% |
| 93 | Keratitis | 15% |
| 94 | Keratoconus | 15% |
| 95 | Lacrimal Duct Obstruction | 15% |
| 96 | Lens dislocation | 15% |
| 97 | Lens Subluxation | 15% |
| 98 | Mydriasis | 15% |
| 99 | Myopia | 15% |
| 100 | Presbyopia | 15% |
| 101 | Pterygium | 15% |
| 102 | Retinal Detachment | 15% |
| 103 | Retinitis | 15% |
| 104 | Scleritis | 15% |
| 105 | Uveitis | 15% |
| 106 | Corneal Neovascularization | 15% |
| 107 | Orbital Pseudotumor | 15% |
| 108 | Cataract | 15% |
| 109 | Pinguecula | 15% |
| 110 | Trichiasis | 15% |
| 111 | Retinitis Pigmentosa | 14.9% |
| 112 | Pigmentary retinopathy | 14.9% |
| 113 | Thymoma | 14.7% |
| 114 | Meningioma | 14.6% |
| 115 | Carcinoma, Pancreatic Ductal | 14.5% |
| 116 | Duane Retraction Syndrome | 14.3% |
| 117 | Testicular Neoplasms | 14.3% |
| 118 | Corneal Scar | 14% |
| 119 | Retinoblastoma | 13.6% |
| 120 | Optic Nerve Glioma | 13.5% |
| 121 | Meningeal Neoplasms | 13.3% |
| 122 | Multiple Endocrine Neoplasia Type 1 | 13.2% |
| 123 | insulinoma | 13.2% |
| 124 | Vipoma | 13.1% |
| 125 | Adrenal Gland Neoplasms | 13% |
| 126 | Gastrointestinal Neoplasms | 13% |
| 127 | Genital Neoplasms, Male | 13% |
| 128 | Liver neoplasms | 13% |
| 129 | Gastrinoma | 13% |
| 130 | Glucagonoma | 13% |
| 131 | Hordeolum | 12.9% |
| 132 | Urologic Neoplasms | 12.9% |
| 133 | Color blindness | 12.8% |
| 134 | Trachoma | 12.7% |
| 135 | Sebaceous Gland Neoplasms | 12.7% |
| 136 | Spinal Neoplasms | 12.7% |
| 137 | Bone Marrow Neoplasms | 12.7% |
| 138 | Opsoclonus-Myoclonus Syndrome | 12.6% |
| 139 | Acoustic Neuroma | 12.5% |
| 140 | Carcinoma 256, Walker | 12.3% |
| 141 | Angle Closure Glaucoma | 12.2% |
| 142 | Glaucoma, Open-Angle | 12.2% |
| 143 | Macular degeneration | 12.2% |
| 144 | Panuveitis | 12.2% |
| 145 | Retinal Drusen | 12.2% |
| 146 | Retinal Necrosis Syndrome, Acute | 12.2% |
| 147 | Retinoschisis | 12.2% |
| 148 | Exfoliation Syndrome | 12.2% |
| 149 | Leukoplakia, Oral | 12.1% |
| 150 | Ocular Motility Disorders | 12.1% |
| 151 | Cyclophoria | 12.1% |
| 152 | Palatal Neoplasms | 12.1% |
| 153 | Paraneoplastic Cerebellar Degeneration | 12.1% |
| 154 | Pupil Disorders | 11.9% |
| 155 | Meningeal Carcinomatosis | 11.8% |
| 156 | Acanthamoeba Keratitis | 11.8% |
| 157 | Eye Hemorrhage | 11.8% |
| 158 | Carcinoma, Ehrlich Tumor | 11.7% |
| 159 | Dermoid Cyst | 11.7% |
| 160 | Carcinoma, Lewis Lung | 11.7% |
| 161 | Keratitis, Herpetic | 11.7% |
| 162 | Cytomegalovirus Retinitis | 11.7% |
| 163 | Vision Disorders | 11.7% |
| 164 | Metamorphopsia | 11.7% |
| 165 | Visual Impairment | 11.7% |
| 166 | Nose Neoplasms | 11.7% |
| 167 | Eye Injuries | 11.6% |
| 168 | Bacterial conjunctivitis | 11.6% |
| 169 | Cyst | 11.5% |
| 170 | Neoplastic Processes | 11.5% |
| 171 | Neoplastic Syndromes, Hereditary | 11.5% |
| 172 | Pregnancy Complications, Neoplastic | 11.5% |
| 173 | Hepatocellular Adenoma | 11.5% |
| 174 | Corneal Perforation | 11.4% |
| 175 | Liver Neoplasms, Experimental | 11.4% |
| 176 | Neoplasms, Experimental | 11.3% |
| 177 | Leydig Cell Tumor | 11.3% |
| 178 | Neoplasms, Neuroepithelial | 11.1% |
| 179 | Gliomatosis cerebri | 11.1% |
| 180 | Anophthalmos | 10.9% |
| 181 | Endophthalmitis | 10.9% |
| 182 | Microphthalmos | 10.9% |
| 183 | Optic Atrophy | 10.9% |
| 184 | Optic Neuritis | 10.9% |
| 185 | Papilledema | 10.9% |
| 186 | Pemphigoid, Benign Mucous Membrane | 10.9% |
| 187 | Retinal Artery Occlusion | 10.9% |
| 188 | Retinopathy of Prematurity | 10.9% |
| 189 | Strabismus | 10.9% |
| 190 | Tolosa-Hunt Syndrome | 10.9% |
| 191 | Orbital Cellulitis | 10.9% |
| 192 | Retinal Vasculitis | 10.9% |
| 193 | Hypertensive Retinopathy | 10.9% |
| 194 | Retrobulbar Hemorrhage | 10.9% |
| 195 | Corneal Endothelial Cell Loss | 10.9% |
| 196 | Anterior uveitis | 10.8% |
| 197 | Uveitis, Posterior | 10.8% |
| 198 | Hyphema | 10.8% |
| 199 | Retinal Neovascularization | 10.8% |
| 200 | Vitreous Hemorrhage | 10.8% |
| 201 | Ear Neoplasms | 10.8% |
| 202 | Lung Neoplasms | 10.8% |
| 203 | Pleural Neoplasms | 10.8% |
| 204 | Medulloblastoma | 10.7% |
| 205 | Neuroectodermal Tumors | 10.7% |
| 206 | Brain Neoplasms | 10.5% |
| 207 | Salivary Gland Neoplasms | 10.5% |
| 208 | Spinal Cord Neoplasms | 10.5% |
| 209 | Tongue Neoplasms | 10.5% |
| 210 | Melanoma, Experimental | 10.5% |
| 211 | melanoma | 10.3% |
| 212 | Uterine Neoplasms | 10.3% |
| 213 | Vaginal Neoplasms | 10.3% |
| 214 | Vulvar Neoplasms | 10.3% |
| 215 | Uterine Cancer | 10.3% |
| 216 | Fallopian Tube Neoplasms | 10.3% |
| 217 | Pituitary Adenoma | 10.2% |
| 218 | Pituitary Neoplasms | 10.2% |
| 219 | Limbic Encephalitis | 10.2% |
| 220 | Erythroplasia | 10% |
| 221 | Follicular cyst | 10% |
| 222 | leukemia | 10% |
| 223 | Mucocele | 10% |
| 224 | Neoplasms, Germ Cell and Embryonal | 10% |
| 225 | Neoplasms, Glandular and Epithelial | 10% |
| 226 | Panophthalmitis | 10% |
| 227 | Pilonidal Cyst | 10% |
| 228 | Thyroglossal Cyst | 10% |
| 229 | Trophoblastic Neoplasms | 10% |
| 230 | Synovial Cyst | 10% |
| 231 | Germ Cell Cancer | 10% |
| 232 | Aberrant Crypt Foci | 10% |
| 233 | Leukemia, Experimental | 9.9% |
| 234 | Carcinosarcoma | 9.7% |
| 235 | Hemangiosarcoma | 9.7% |
| 236 | Leukemia L1210 | 9.7% |
| 237 | Leukemia P388 | 9.7% |
| 238 | lymphangiosarcoma | 9.7% |
| 239 | Prolactinoma | 9.7% |
| 240 | Growth Hormone-Secreting Pituitary Adenoma | 9.7% |
| 241 | Adenoma, Acidophil | 9.6% |
| 242 | Ganglioneuroma | 9.6% |
| 243 | Glioma | 9.6% |
| 244 | Malignant Glioma | 9.6% |
| 245 | Bronchial Neoplasms | 9.5% |
| 246 | Multiple Pulmonary Nodules | 9.4% |
| 247 | Supratentorial Neoplasms | 9.3% |
| 248 | Nephroblastoma | 9.3% |
| 249 | Sarcoma 180 | 9.3% |
| 250 | Carcinoid Tumor | 9.2% |
| 251 | Endometrial Neoplasms | 9.2% |
| 252 | Neurilemmoma | 9.2% |
| 253 | Hutchinson's Melanotic Freckle | 9.2% |
| 254 | Melanoma, Amelanotic | 9.2% |
| 255 | Sarcoma, Experimental | 9.2% |
| 256 | Lambert-Eaton Myasthenic Syndrome | 9.1% |
| 257 | Pharyngeal Neoplasms | 9% |
| 258 | Neoplasms, Radiation-Induced | 8.9% |
| 259 | ovarian neoplasm | 8.9% |
| 260 | Esotropia | 8.8% |
| 261 | Exotropia | 8.8% |
| 262 | Choroidal Neovascularization | 8.8% |
| 263 | Astrocytoma | 8.8% |
| 264 | Ependymoma | 8.8% |
| 265 | oligodendroglioma | 8.8% |
| 266 | Ganglioglioma | 8.8% |
| 267 | gliosarcoma | 8.8% |
| 268 | Anaplastic astrocytoma | 8.8% |
| 269 | Anaplastic Oligodendroglioma | 8.8% |
| 270 | Choriocarcinoma | 8.8% |
| 271 | Basal cell carcinoma | 8.8% |
| 272 | Carcinoma, Papillary | 8.8% |
| 273 | Squamous cell carcinoma | 8.8% |
| 274 | Chondrosarcoma | 8.8% |
| 275 | Craniopharyngioma | 8.8% |
| 276 | Cystadenoma | 8.8% |
| 277 | leiomyosarcoma | 8.8% |
| 278 | liposarcoma | 8.8% |
| 279 | Mesothelioma | 8.8% |
| 280 | synovial sarcoma | 8.8% |
| 281 | Neuroectodermal Tumor, Melanotic | 8.8% |
| 282 | Angiomyolipoma | 8.8% |
| 283 | Clear Cell Sarcoma of Soft Tissue | 8.8% |
| 284 | Alveolar Soft Part Sarcoma | 8.8% |
| 285 | Neuroendocrine Tumors | 8.8% |
| 286 | Central Nervous System Cysts | 8.8% |
| 287 | Sarcoma, Myeloid | 8.8% |
| 288 | Carcinoma, Basal Cell | 8.8% |
| 289 | Uveal Neoplasms | 8.7% |
| 290 | Optic Neuropathy, Ischemic | 8.7% |
| 291 | Anterior Ischemic Optic Neuropathy | 8.7% |
| 292 | Brain Stem Neoplasms | 8.7% |
| 293 | Bile Duct Neoplasms | 8.7% |
| 294 | gallbladder neoplasm | 8.7% |
| 295 | Intestinal Neoplasms | 8.7% |
| 296 | Penile Neoplasms | 8.7% |
| 297 | Prostatic Neoplasms | 8.7% |
| 298 | Stomach Neoplasms | 8.7% |
| 299 | Malignant Carcinoid Syndrome | 8.7% |
| 300 | Adrenocortical carcinoma | 8.7% |
| 301 | Retinal Vein Occlusion | 8.6% |
| 302 | Polycythemia Vera | 8.5% |
| 303 | Anisocoria | 8.5% |
| 304 | Diabetic Retinopathy | 8.5% |
| 305 | Tonic Pupil | 8.5% |
| 306 | Eye pain | 8.5% |
| 307 | Orbital Myositis | 8.5% |
| 308 | Glioblastoma | 8.5% |
| 309 | Neuroblastoma | 8.5% |
| 310 | Glioblastoma Multiforme | 8.5% |
| 311 | Diplopia | 8.4% |
| 312 | Scotoma | 8.4% |
| 313 | Photophobia | 8.4% |
| 314 | Amaurosis | 8.4% |
| 315 | Blindness | 8.4% |
| 316 | Choroid Plexus Papilloma | 8.4% |
| 317 | granulosa cell tumor | 8.4% |
| 318 | Carcinoma, Ovarian Epithelial | 8.4% |
| 319 | Cystadenocarcinoma | 8.3% |
| 320 | Fibrosarcoma | 8.3% |
| 321 | Osteosarcoma | 8.3% |
| 322 | Mucoepidermoid Carcinoma | 8.3% |
| 323 | Ganglioneuroblastoma | 8.3% |
| 324 | Leukemia, Radiation-Induced | 8.3% |
| 325 | Mesoblastic Nephroma | 8.2% |
| 326 | Adenofibroma | 8.1% |
| 327 | Fibroadenoma | 8.1% |
| 328 | Malignant Fibrous Histiocytoma | 8.1% |
| 329 | Bowen's Disease | 7.8% |
| 330 | Paraganglioma | 7.8% |
| 331 | Rhabdomyosarcoma | 7.8% |
| 332 | Giant Cell Tumor of Bone | 7.8% |
| 333 | Hypopharyngeal Neoplasms | 7.8% |
| 334 | Pleural Effusion, Malignant | 7.8% |
| 335 | Hypopharyngeal Cancer | 7.8% |
| 336 | Laryngeal neoplasm | 7.7% |
| 337 | Parotid Neoplasms | 7.6% |
| 338 | Prostatic Neoplasms, Castration-Resistant | 7.6% |
| 339 | Adenomatous Polyposis Coli | 7.6% |
| 340 | Leukemia, Plasma Cell | 7.6% |
| 341 | Ophthalmia Neonatorum | 7.6% |
| 342 | Nelson Syndrome | 7.6% |
| 343 | Dermatofibrosarcoma | 7.6% |
| 344 | Dermatofibrosarcoma Protuberans | 7.6% |
| 345 | Tuberous Sclerosis | 7.6% |
| 346 | Renal Cell Carcinoma | 7.5% |
| 347 | Papillary Renal Cell Carcinoma | 7.5% |
| 348 | Leukoplakia | 7.4% |
| 349 | Lymphocele | 7.4% |
| 350 | Pancreatic Cyst | 7.4% |
| 351 | Pheochromocytoma | 7.4% |
| 352 | Alveolar rhabdomyosarcoma | 7.4% |
| 353 | Adenoma | 7.3% |
| 354 | Ameloblastoma | 7.3% |
| 355 | Angiokeratoma | 7.3% |
| 356 | Bladder Neoplasm | 7.3% |
| 357 | Carcinoma | 7.3% |
| 358 | Chordoma | 7.3% |
| 359 | Hemangioma | 7.3% |
| 360 | hemangiopericytoma | 7.3% |
| 361 | Kidney Neoplasm | 7.3% |
| 362 | Lymphangioma | 7.3% |
| 363 | Mesenchymoma | 7.3% |
| 364 | Nevus | 7.3% |
| 365 | Teratoma | 7.3% |
| 366 | Ureteral Neoplasms | 7.3% |
| 367 | Urethral Neoplasms | 7.3% |
| 368 | Hepatoblastoma | 7.3% |
| 369 | Mixed Tumor, Mullerian | 7.3% |
| 370 | Germinoma | 7.3% |
| 371 | Teratocarcinoma | 7.3% |
| 372 | Angiofibroma | 7.3% |
| 373 | Sarcoma | 7.3% |
| 374 | Epithelioma | 7.3% |
| 375 | Barrett Esophagus | 7.3% |
| 376 | Breast Cyst | 7.3% |
| 377 | Histiocytic Disorders, Malignant | 7.3% |
| 378 | Actinic keratosis | 7.3% |
| 379 | Mediastinal Cyst | 7.3% |
| 380 | Neoplasm Invasiveness | 7.3% |
| 381 | Neoplasm Metastasis | 7.3% |
| 382 | Neoplasm Recurrence, Local | 7.3% |
| 383 | Parovarian Cyst | 7.3% |
| 384 | Pericardial Cyst | 7.3% |
| 385 | Thymic Cyst | 7.3% |
| 386 | Carcinogenesis | 7.3% |
| 387 | Myxoid cyst | 7.3% |
| 388 | Metastasis | 7.3% |
| 389 | Tonsillar Neoplasms | 7.2% |
| 390 | Cerebellar Neoplasms | 7.2% |
| 391 | Carcinoma, Endometrioid | 7.2% |
| 392 | Lymphomatoid Granulomatosis | 7.1% |
| 393 | Uveomeningoencephalitic Syndrome | 7.1% |
| 394 | CHARGE Syndrome | 7.1% |
| 395 | Optic Atrophy, Hereditary, Leber | 7.1% |
| 396 | Myelitis, Transverse | 7.1% |
| 397 | Congenital nystagmus | 7.1% |
| 398 | Herpes Zoster Ophthalmicus | 7.1% |
| 399 | Carcinoid Heart Disease | 7% |
| 400 | Ophthalmoplegia | 7% |
| 401 | External Ophthalmoplegia | 7% |
| 402 | Amblyopia | 7% |
| 403 | Hemianopsia | 6.9% |
| 404 | Composite Lymphoma | 6.9% |
| 405 | Amaurosis Fugax | 6.9% |
| 406 | Blindness, Cortical | 6.9% |
| 407 | Basal Cell Nevus Syndrome | 6.6% |
| 408 | Nasopharyngeal carcinoma | 6.6% |
| 409 | Hydatidiform Mole | 6.5% |
| 410 | Cecal Neoplasms | 6.5% |
| 411 | Duodenal Neoplasms | 6.5% |
| 412 | Neurofibrosarcoma | 6.3% |
| 413 | Appendiceal Neoplasms | 6.1% |
| 414 | Colonic Neoplasms | 6.1% |
| 415 | Rectal Neoplasms | 6.1% |
| 416 | Adenocarcinoma | 6% |
| 417 | Carcinoma in Situ | 6% |
| 418 | Carcinoma, Transitional Cell | 6% |
| 419 | Phyllodes Tumor | 6% |
| 420 | Dysgerminoma | 6% |
| 421 | Hemangioendothelioma | 6% |
| 422 | Lipoma | 6% |
| 423 | Myoma | 6% |
| 424 | Myxoma | 6% |
| 425 | Neuroma | 6% |
| 426 | Papilloma | 6% |
| 427 | Pseudomyxoma Peritonei | 6% |
| 428 | Seminoma | 6% |
| 429 | Papillomatosis | 6% |
| 430 | Angiolipoma | 6% |
| 431 | Myelolipoma | 6% |
| 432 | Neoplasms, Bone Tissue | 6% |
| 433 | Neoplasms, Fibrous Tissue | 6% |
| 434 | Smooth Muscle Tumor | 6% |
| 435 | Adenomatosis, Pulmonary | 6% |
| 436 | Adenomatous Polyps | 6% |
| 437 | Carcinoma, Large Cell | 6% |
| 438 | Carcinoma, Small Cell | 6% |
| 439 | Desmoplastic Small Round Cell Tumor | 6% |
| 440 | Chondroma | 6% |
| 441 | Enchondroma | 6% |
| 442 | Endometrial Stromal Sarcoma | 5.9% |
| 443 | Graves Disease | 5.9% |
| 444 | Horner Syndrome | 5.8% |
| 445 | Nasopharyngeal Neoplasms | 5.8% |
| 446 | Lymphoma | 5.7% |
| 447 | Mandibulofacial Dysostosis | 5.7% |
| 448 | Lymphangioleiomyomatosis | 5.7% |
| 449 | Colorectal Neoplasms | 5.7% |
| 450 | Corpus Luteum Cyst | 5.7% |
| 451 | Ovarian Cysts | 5.7% |
| 452 | Denys-Drash Syndrome | 5.6% |
| 453 | Adenoid Cystic Carcinoma | 5.4% |
| 454 | fibroma | 5.4% |
| 455 | Fibromatosis | 5.4% |
| 456 | Osteoblastoma | 5.4% |
| 457 | Osteoma | 5.4% |
| 458 | Rhabdomyoma | 5.4% |
| 459 | Chondromatosis | 5.4% |
| 460 | Adenocarcinoma, Clear Cell | 5.4% |
| 461 | Cholangiocarcinoma | 5.4% |
| 462 | Cervical Intraepithelial Neoplasia | 5.4% |
| 463 | Hemangioblastoma | 5.4% |
| 464 | Lymphoma, Extranodal NK-T-Cell | 5.4% |
| 465 | Pancreatic Pseudocyst | 5.4% |
| 466 | Plasmacytoma | 5.4% |
| 467 | Malignant histiocytosis | 5.3% |
| 468 | Lymphatic Metastasis | 5.3% |
| 469 | Neoplasms, Unknown Primary | 5.3% |
| 470 | Leukemic Infiltration | 5.3% |
| 471 | Histiocytic sarcoma | 5.3% |
| 472 | Neoplasm Micrometastasis | 5.3% |
| 473 | Aicardi's syndrome | 5.2% |
| 474 | Paranasal Sinus Neoplasms | 5.1% |
| 475 | Anus Neoplasms | 5.1% |
| 476 | Sigmoid Neoplasms | 5.1% |
| 477 | Fibromatosis, Aggressive | 5.1% |
| 478 | Fibromatosis, Abdominal | 5.1% |
| 479 | Klatskin Tumor | 5.1% |
| 480 | Kearns-Sayre syndrome | 4.8% |
| 481 | Choledochal Cyst | 4.8% |
| 482 | Maxillary Sinus Neoplasms | 4.7% |
| 483 | Peutz-Jeghers Syndrome | 4.6% |
| 484 | Albinism | 4.6% |
| 485 | Leukemia, Myelomonocytic, Chronic | 4.4% |
| 486 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.4% |
| 487 | Sicca Syndrome | 4.3% |
| 488 | Sjogren's Syndrome | 4.3% |
| 489 | Hodgkin Disease | 4.2% |
| 490 | Lymphoma, Non-Hodgkin | 4.2% |
| 491 | Polycystic Ovary Syndrome | 4.1% |
| 492 | Miller Fisher Syndrome | 4% |
| 493 | Mastocytoma | 4% |
| 494 | Mastocytosis, Systemic | 3.9% |
| 495 | Leukemia, Myeloid, Chronic-Phase | 3.9% |
| 496 | Ophthalmoplegic Migraine | 3.8% |
| 497 | Progressive supranuclear palsy | 3.8% |
| 498 | Behcet Syndrome | 3.7% |
| 499 | Mastocytosis | 3.5% |
| 500 | Sturge-Weber Syndrome | 3.5% |
| 501 | Cell Transformation, Viral | 3.5% |
| 502 | Gastrointestinal Stromal Tumors | 3.5% |
| 503 | Hemangioma, Cavernous | 3.5% |
| 504 | Primary amyloidosis | 3.5% |
| 505 | Leukemia, T-Cell | 3.4% |
| 506 | Leukemia, B-Cell | 3.4% |
| 507 | neurofibroma | 3.4% |
| 508 | Lymphoma, Follicular | 3.4% |
| 509 | T-Cell Lymphoma | 3.4% |
| 510 | Mantle cell lymphoma | 3.4% |
| 511 | Neuromyelitis Optica | 3.4% |
| 512 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.1% |
| 513 | Leukemia, Large Granular Lymphocytic | 3.1% |
| 514 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.1% |
| 515 | Lymphoma, T-Cell, Cutaneous | 3.1% |
| 516 | Lymphoma, AIDS-Related | 3.1% |
| 517 | Enteropathy-Associated T-Cell Lymphoma | 3.1% |
| 518 | Primary Effusion Lymphoma | 3.1% |
| 519 | Alstrom Syndrome | 3% |
| 520 | Dupuytren Contracture | 3% |
| 521 | Urticaria Pigmentosa | 2.9% |
| 522 | Mycosis Fungoides | 2.9% |
| 523 | Lymphomatoid Papulosis | 2.9% |
| 524 | Plasmablastic lymphoma | 2.9% |
| 525 | Xeroderma Pigmentosum | 2.8% |
| 526 | Waldenstrom Macroglobulinemia | 2.6% |
| 527 | Multiple Myeloma | 2.6% |
| 528 | Zollinger-Ellison syndrome | 2.3% |
| 529 | Burkitt Lymphoma | 2.2% |
| 530 | Sezary Syndrome | 2% |
| 531 | Radicular Cyst | 2% |